RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on revolutionizing treatments for oncology and inflammatory diseases with its oral small molecule therapies. Leveraging a proprietary drug discovery platform that targets key immune regulatory pathways, RAPT is advancing a promising pipeline aimed at addressing critical unmet medical needs. The company is strategically positioned to deliver novel therapeutic options through its innovative approaches, contributing significantly to the field of personalized medicine in immunology. With its commitment to clinical excellence, RAPT endeavors to enhance patient outcomes and reshape the therapeutic landscape.
Click "Analyze" to generate stock analysis
RAPT Price Trend and Signals
RAPT Option Volumes & Open Interests (aggregated)
RAPT Put Call Ratios and IV (aggregated)
RAPT Financials
2025-12-19Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-12-19Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-12-19Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.